Literature DB >> 12028791

Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

J Fajkus1, M Simícková, J Maláska.   

Abstract

The past decade has witnessed an explosion of knowledge concerning the structure and function of chromosome terminal structures-telomeres. Today's telomere research has advanced from a pure descriptive approach of DNA and protein components to an elementary understanding of telomere metabolism, and now to promising applications in medicine. These applications include 'passive' ones, among which the use of analysis of telomeres and telomerase (a cellular reverse transcriptase that synthesizes telomeres) for cancer diagnostics is the best known. The 'active' applications involve targeted downregulation or upregulation of telomere synthesis, either to mortalize immortal cancer cells, or to rejuvenate mortal somatic cells and tissues for cellular transplantations, respectively. This article reviews the basic data on structure and function of human telomeres and telomerase, as well as both passive and active applications of human telomere biology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028791      PMCID: PMC1692969          DOI: 10.1098/rstb.2001.1053

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  162 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase.

Authors:  S Kharbanda; V Kumar; S Dhar; P Pandey; C Chen; P Majumder; Z M Yuan; Y Whang; W Strauss; T K Pandita; D Weaver; D Kufe
Journal:  Curr Biol       Date:  2000-05-18       Impact factor: 10.834

3.  RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase.

Authors:  S Le; J K Moore; J E Haber; C W Greider
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

4.  Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).

Authors:  K S Koeneman; C X Pan; J K Jin; J M Pyle; R C Flanigan; T V Shankey; M O Diaz
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

5.  Interaction of human Ku70 with TRF2.

Authors:  K Song; D Jung; Y Jung; S G Lee; I Lee
Journal:  FEBS Lett       Date:  2000-09-08       Impact factor: 4.124

6.  Telomerase activity and survival of patients with node-positive breast cancer.

Authors:  G M Clark; C K Osborne; D Levitt; F Wu; N W Kim
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

7.  Gastric cancer with high telomerase activity shows rapid development and invasiveness.

Authors:  Y Kakeji; Y Maehara; T Koga; K Shibahara; A Kabashima; E Tokunaga; K Sugimachi
Journal:  Oncol Rep       Date:  2001 Jan-Feb       Impact factor: 3.906

8.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.

Authors:  J Albanell; W Han; B Mellado; R Gunawardane; H I Scher; E Dmitrovsky; M A Moore
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

10.  Mutation of yeast Ku genes disrupts the subnuclear organization of telomeres.

Authors:  T Laroche; S G Martin; M Gotta; H C Gorham; F E Pryde; E J Louis; S M Gasser
Journal:  Curr Biol       Date:  1998-05-21       Impact factor: 10.834

View more
  4 in total

1.  HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction.

Authors:  Eva Polanská; Zuzana Dobšáková; Martina Dvořáčková; Jiří Fajkus; Michal Štros
Journal:  Chromosoma       Date:  2012-04-28       Impact factor: 4.316

2.  Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells.

Authors:  Eva Majerová; Miloslava Fojtová; Iva Mozgová; Miroslava Bittová; Jiří Fajkus
Journal:  Plant Mol Biol       Date:  2011-08-25       Impact factor: 4.076

3.  Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Authors:  Kimberly S Butler; William C Hines; Christopher M Heaphy; Jeffrey K Griffith
Journal:  Cancer Med       Date:  2012-07-24       Impact factor: 4.452

4.  Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.

Authors:  Baoshan Liu; Rongdi Yan; Jie Zhang; Bin Wang; Hu Sun; Xing Cui
Journal:  Turk J Haematol       Date:  2017-04-13       Impact factor: 2.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.